Founded in 2012, Chengdu Antejin biotech is a vaccine R&D scale up lab with a full line of vaccine preclinical research equipment.
Fortune Rock is a biotech company, focused on Biological innovative drug development, such as HSA-GCSF, HSA-IFN and HSA-EPO, completing Phase II, Phase I and IND respectively.
An international pharmaceutical company focusing on cancer treatment.
Focused on innovative research in respiratory drugs, is a leader in respiratory medicine.
IMPACT is a biotech company, focused on DNA damage Best-in-class drugs R&D. Its core drug, PARP inhibitor will be in Phase II soon. IMPACT has been invested by many institutional investors, such as LAV and WuXi App Tec.